"Pratia Gdynia to doświadczony ośrodek badań klinicznych. Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej."

During the past decade, Centrum Medyczne Pratia Gdynia conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 9 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Medyczne Pratia Gdynia" #1 sponsor was "Shire" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Amgen" with 1 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored and "Galapagos NV" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Gdynia" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Gdynia" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Postmenopausal Osteoporosis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Gdynia" in a lesser frequency.

Most popular intervention types in "Centrum Medyczne Pratia Gdynia" are "Drug" (15 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (4 trials), "Filgotinib" (2 trials), "Placebo to match filgotinib" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Medyczne Pratia Gdynia" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Medyczne Pratia Gdynia". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Centrum Medyczne Pratia Gdynia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Medyczne Pratia Gdynia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".